Deals
Northwest Biotherapeutics Raises $15M in RDO at 8% Discount via H.C. Wainwright
|
Northwest Biotherapeutics, Inc. (NWBO) announced that it has raised $14,999,998 in a Registered Direct transaction. The common stock was sold at $6.60 per share, an approximate 8% discount to the market price ($7.17) of NWBO at deal announcement. H.C. Wainwright & Co. acted as the exclusive agent on the transaction. The transaction is expected to close on April 14, 2014.